Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Contemporary Clinical Trials|November 12, 2024
The eACT study design and methods: A sequential, multiple assignment, randomized trial of A novel adherence intervention for youth with epilepsyJanelle L Wagner, Anup D Patel, Heather Huszti, et al.The Journal of Pain|May 15, 2023
Cost-Effectiveness Analysis Evaluating Delivery Strategies for Pain Coping Skills Training in Women With Breast CancerYanhong Li, Shelby D Reed, Joseph G Winger, et al.Journal of Clinical and Translational Science|May 27, 2022
Telehealth and racial disparities in colorectal cancer screening: A pilot study of how virtual clinician characteristics influence screening intentionsEric J Cooks, Kyle A Duke, Jordan M Neil, et al.Pain|April 20, 2023
Behavioral cancer pain intervention dosing: results of a Sequential Multiple Assignment Randomized TrialTamara J Somers, Joseph G Winger, Hannah M Fisher, et al.American Journal of Preventive Medicine|April 23, 2021
A Pilot Study Examining the Efficacy of Delivering Colorectal Cancer Screening Messages via Virtual Health AssistantsJanice L Krieger, Jordan M Neil, Kyle A Duke, et al.Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.Contemporary Clinical Trials|April 15, 2017
Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMARTSarah A Kelleher, Caroline S Dorfman, Jen C Plumb Vilardaga, et al.Nature Medicine|September 14, 2024
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialKatia Khoury, Jane L Meisel, Christina Yau, et al.Nature Medicine|September 14, 2024
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialRebecca A Shatsky, Meghna S Trivedi, Christina Yau, et al.Pageof 9